home · filing · 0001654954-21-012630
8-K filed November 26, 2021, 6:59 PM ET
ticker ZOMDF
CIK 0001684144
leadership
confidence high
sentiment neutral
materiality 0.60
Zomedica CCO Bruk Herbst departs; separation agreement with benefits for termination without cause
Zomedica Corp.
Bruk Herbst separated from Zomedica as Chief Commercial Officer effective Nov 19, 2021.
Separation agreement provides benefits for termination without cause per his employment agreement and home office equipment (excluding laptop).
Agreement includes mutual release of claims, confidentiality, non-disparagement, and non-solicitation obligations.
Herbst had 21 days to consider and 7 days to revoke the agreement; it was signed on Nov 19, 2021.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Bruk Herbst
Chief Commercial Officer
Effective 2021-11-19
Filed November 26, 2021, 6:59 PM ET
On November 19, 2021, Bruk Herbst was separated from employment as Chief Commercial Officer of Zomedica Corp. (the “Company”).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bruk Herbst departed as Chief Commercial Officer at Zomedica Corp..
Action separated from employment
Role Chief Commercial Officer
Exact text from the filing
On November 19, 2021, Bruk Herbst was separated from employment as Chief Commercial Officer of Zomedica Corp. (the “Company”).
View on SEC.gov
Source: SEC EDGAR
accession 0001654954-21-012630
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.